Research articlePublished 2015
Economic Impact of Microarray-Based Rapid Detection of Gram-Positive Organisms in Blood Cultures
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
We assessed the clinical and economic impact of using the microarray-based Verigene Gram positive blood culture (BC-GP) test to identify gram positive bacteria in blood cultures. The main advantage of employing this test in comparison to conventional culture techniques resided on identifying the causative organism an average of 42.8 hours prior than conventional culture techniques. The microarray-based test results allowed providers to tailor antibiotic therapy and decide whether to admit/discharge a patient sooner, which reflected over $21,000 in hospital savings for the 105 cases analyzed in this study. The implementation of the Verigene BC-GP in our Microbiology Laboratory presented an economic advantage when compared to conventional workup and was shown to improve ongoing antimicrobial stewardship and patient care.
Subjects
MicrobiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalMedical Microbiology & Diagnosis
- SubjectMicrobiology
- BylineArticles whose byline prints “Paul Mariani”
- BylineArticles whose byline prints “Jesse Breidenbach”
- BylineArticles whose byline prints “Felix Roth”
